Boaz Inbal

Title: Boaz Inbal: Innovator in Pharmaceutical Compounds

Introduction

Boaz Inbal is a notable inventor based in Kfar Shmuel, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target 5-HT receptors. With a total of 11 patents to his name, Inbal's work has the potential to impact various medical conditions.

Latest Patents

Inbal's latest patents include innovative compounds and methods for their application. One of his notable inventions is related to bicyclic compounds that may serve as modulators of 5-HT receptors. This patent outlines methods for making and using these compounds. Another significant patent involves thienopyridinone compounds, which are described as 5-HT receptor agonists and partial agonists. These compounds are represented by a specific formula and are intended for treating a range of diseases, including Alzheimer's disease, cognitive disorders, and various gastrointestinal issues. The patents also cover methods of preparation and novel intermediates, enhancing the therapeutic potential of these compounds.

Career Highlights

Throughout his career, Boaz Inbal has worked with prominent companies in the pharmaceutical industry. He has been associated with Epix Delaware, Inc. and Nanotherapeutics, Inc., where he has contributed to the advancement of innovative treatments. His expertise in the field has positioned him as a valuable asset in the development of new therapeutic solutions.

Collaborations

Inbal has collaborated with several professionals in his field, including Dale S. Dhanoa and Oren Becker. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Boaz Inbal's work in developing pharmaceutical compounds demonstrates his commitment to advancing medical science. His innovative patents and collaborations highlight his significant role in the field, paving the way for potential breakthroughs in treatment options.